Naijin Xu

664 total citations
20 papers, 513 citations indexed

About

Naijin Xu is a scholar working on Molecular Biology, Surgery and Oncology. According to data from OpenAlex, Naijin Xu has authored 20 papers receiving a total of 513 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 4 papers in Surgery and 4 papers in Oncology. Recurrent topics in Naijin Xu's work include Bladder and Urothelial Cancer Treatments (3 papers), Extracellular vesicles in disease (2 papers) and Renal cell carcinoma treatment (2 papers). Naijin Xu is often cited by papers focused on Bladder and Urothelial Cancer Treatments (3 papers), Extracellular vesicles in disease (2 papers) and Renal cell carcinoma treatment (2 papers). Naijin Xu collaborates with scholars based in China, Japan and United States. Naijin Xu's co-authors include Hui Liu, Guanqun Chen, Peng Huang, Xun Xu, Wenfeng Lin, Chunxiao Liu, Masami Watanabe, Chaoming Li, Yasutomo Nasu and Motoo Araki and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Molecules and BioMed Research International.

In The Last Decade

Naijin Xu

20 papers receiving 504 citations

Peers

Countries citing papers authored by Naijin Xu

Since Specialization

Citations

This map shows the geographic impact of Naijin Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Naijin Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Naijin Xu more than expected).

Fields of papers citing papers by Naijin Xu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Naijin Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Naijin Xu. The network helps show where Naijin Xu may publish in the future.

Co-authorship network of co-authors of Naijin Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Naijin Xu. A scholar is included among the top collaborators of Naijin Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Naijin Xu. Naijin Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Nitroxoline suppresses metastasis in bladder cancer via EGR1/circNDRG1/miR-520h/smad7/EMT signaling pathway 2022 ·International Journal of Biological Sciences ·Liangliang Ren, Minxiao Jiang, Dingwei Xue, Huan Wang, Zeyi Lu, Lifeng Ding, Haiyun Xie, Ruyue Wang, Wenqin Luo, Li Xu, Mingchao Wang, Shicheng Yu, Sheng Cheng, Liqun Xia, Haifeng Yu, Peng Huang, Naijin Xu, Gonghui Li	20
2	Discovery and Validation of Nitroxoline as a Novel STAT3 Inhibitor in Drug-resistant Urothelial Bladder Cancer 2021 ·International Journal of Biological Sciences ·Wenfeng Lin, (unknown), Takuya Sadahira, Naijin Xu, Koichiro Wada, Chunxiao Liu, Motoo Araki, Xun Xu, Masami Watanabe, Yasutomo Nasu, Peng Huang	20
3	Dual-Functional PLGA Nanoparticles Co-Loaded with Indocyanine Green and Resiquimod for Prostate Cancer Treatment 2021 ·International Journal of Nanomedicine ·Wenfeng Lin, Chaoming Li, Naijin Xu, Masami Watanabe, Rui Xue, Xun Xu, Motoo Araki, Ruifen Sun, Chunxiao Liu, Yasutomo Nasu, Peng Huang	37
4	Exosomes Promote the Transition of Androgen-Dependent Prostate Cancer Cells into Androgen-Independent Manner Through Up-Regulating the Heme Oxygenase-1 2021 ·International Journal of Nanomedicine ·(unknown), (unknown), Naijin Xu, Peng Xu, Wenfeng Lin, Chunxiao Liu, Peng Huang	17
5	Nitroxoline inhibits bladder cancer progression by reversing EMT process and enhancing anti-tumor immunity 2020 ·Journal of Cancer ·Naijin Xu, Wenfeng Lin, (unknown), Takuya Sadahira, Xun Xu, Masami Watanabe, Kai Guo, Motoo Araki, Gonghui Li, Chunxiao Liu, Yasutomo Nasu, Peng Huang	11
6	The Novel Combination of Nitroxoline and PD-1 Blockade, Exerts a Potent Antitumor Effect in a Mouse Model of Prostate Cancer 2019 ·International Journal of Biological Sciences ·Naijin Xu, (unknown), (unknown), (unknown), Chaoming Li, Xun Xu, (unknown), Qiang Li, Motoo Araki, Koichiro Wada, Yasutomo Nasu, Peng Huang	20
7	Induction of cells with prostate cancer stem-like properties from mouse induced pluripotent stem cells via conditioned medium. 2018 ·PubMed ·Naijin Xu, (unknown), Masami Watanabe, (unknown), Hao Hu, Na Li, Motoo Araki, Koichiro Wada, Xun Xu, Chunxiao Liu, Yasutomo Nasu, Peng Huang	11
8	Quantitative Assessment of the Effects of Reducing Agents on Biological Macromolecules and on the Possible Repair of Oxidative Damage 2018 ·BioMed Research International ·Jianan Zhao, Naijin Xu, Hui Liu	1
9	Glaucocalyxin A induces G2/M cell cycle arrest and apoptosis through the PI3K/Akt pathway in human bladder cancer cells 2018 ·International Journal of Biological Sciences ·Wenfeng Lin, (unknown), Naijin Xu, (unknown), Xun Xu, Hulin Li, Chaoming Li, Yubo Gao, Masami Watanabe, Chunxiao Liu, Peng Huang	64
10	Bufalin suppresses the proliferation and metastasis of renal cell carcinoma by inhibiting the PI3K/Akt/mTOR signaling pathway 2018 ·Oncology Letters ·(unknown), Wenfeng Lin, (unknown), Naijin Xu, Xun Xu, Binshen Chen, Masami Watanabe, Chunxiao Liu, Peng Huang	28
11	Effects of Glutathione S‐Transferase Gene Polymorphisms and Antioxidant Capacity per Unit Albumin on the Pathogenesis of Chronic Obstructive Pulmonary Disease 2017 ·Oxidative Medicine and Cellular Longevity ·(unknown), Naijin Xu, Zhen Wang, Hui Liu	20
12	Antioxidative Categorization of Twenty Amino Acids Based on Experimental Evaluation 2017 ·Molecules ·Naijin Xu, Guanqun Chen, Hui Liu	152
13	Synergistic effects of the immune checkpoint inhibitor CTLA-4 combined with the growth inhibitor lycorine in a mouse model of renal cell carcinoma 2017 ·Oncotarget ·(unknown), Peng Xu, (unknown), Naijin Xu, Xun Xu, Yawen Xu, Takuya Sadahira, Motoo Araki, Koichiro Wada, Eiji Matsuura, Masami Watanabe, Junxia Zheng, Pinghua Sun, Peng Huang, Yasutomo Nasu, Chunxiao Liu	29
14	Comprehensive Evaluation and Clinical Application of Combined Redox Assay Methods to Determine Total Antioxidant Capacity 2017 ·Current Analytical Chemistry ·(unknown), Naijin Xu, Min He, Hui Liu	2
15	Lycorine induces apoptosis of bladder cancer T24 cells by inhibiting phospho-Akt and activating the intrinsic apoptotic cascade 2016 ·Biochemical and Biophysical Research Communications ·(unknown), (unknown), (unknown), Jin Zhong, Peng Xu, Naijin Xu, Xun Xu, Yawen Xu, (unknown), Junxia Zheng, Chunxiao Liu, Peng Huang	42
16	Quantitative Assessment of the Effects of Oxidants on Antigen‐Antibody Binding In Vitro 2016 ·Oxidative Medicine and Cellular Longevity ·Shuang Han, Guanyu Wang, Naijin Xu, Hui Liu	5
17	Real-time monitoring of tumor progression and drug responses in a preclinical mouse model of prostate cancer 2016 ·Oncotarget ·Peng Xu, Naijin Xu, Kai Guo, Xun Xu, (unknown), Eiji Matsuura, Chunxiao Liu, Hiromi Kumon, Peng Huang	10
18	Increased expression of metastasis-associated in colon cancer-1 in renal cell carcinoma is associated with poor prognosis. 2015 ·PubMed ·Zhong Jin, Naijin Xu, Kai Guo, Peng Xu, Pengju Li, (unknown), (unknown), Shaobo Zheng, Chunxiao Liu, Xun Xu, Peng Huang	4
19	A New Method for Measuring Total Antioxidant Capacity in Urine Using the Iodine Starch Agar Based on Agar diffusion 2015 ·Current Analytical Chemistry ·Ying Zhou, Naijin Xu, Meijuan Zhang, Hui Liu	4
20	A combination of YM-155, a small molecule survivin inhibitor, and IL-2 potently suppresses renal cell carcinoma in murine model 2015 ·Oncotarget ·Kai Guo, Peng Huang, Naijin Xu, Peng Xu, Haruki Kaku, Shaobo Zheng, Xun Xu, Eiji Matsuura, Chunxiao Liu, Hiromi Kumon	16

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact